Cargando…
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
Tuberculosis (TB) is a major global health problem and there is a dire need for an improved treatment. A strategy to combine vaccination with drug treatment, termed therapeutic vaccination, is expected to provide benefit in shortening treatment duration and augmenting treatment success rate. RUTI ca...
Autores principales: | Prabowo, Satria A., Painter, Hannah, Zelmer, Andrea, Smith, Steven G., Seifert, Karin, Amat, Merce, Cardona, Pere-Joan, Fletcher, Helen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503078/ https://www.ncbi.nlm.nih.gov/pubmed/31114572 http://dx.doi.org/10.3389/fimmu.2019.00894 |
Ejemplares similares
-
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
por: Painter, Hannah, et al.
Publicado: (2020) -
Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
por: Prabowo, Satria A., et al.
Publicado: (2019) -
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
por: Nell, Andre S., et al.
Publicado: (2014) -
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
por: Pennisi, Marzio, et al.
Publicado: (2019) -
High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2018)